The US Food and Drug Administration and probiotics: regulatory categorization

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Frederick H Degnan

Abstract

Probiotics are living microorganisms that, when consumed, have the potential to confer a beneficial health effect. Unfortunately for purveyors of probiotic products, the system of regulation delineated in the Food, Drug, and Cosmetic Act is anything but "one size fits all." How a probiotic product is used or is intended to be used will govern the regulatory category or categories that the US Food and Drug Administration (FDA) will assign to the product. The extent and nature of the restraints and data-collection requirements that may be imposed on the marketing of a product hinge on how a product is categorized under the Act. More specifically, the categorization of a product governs the respective regulatory burdens of an industry sponsor and the FDA. Premarket systems, such as those for new drugs and biologics, place a heavy evidentiary burden on the sponsor of a product. Postmarket systems, such as those for dietary supplements, place, at least initially, a higher regulatory evidentiary burden on the FDA than on the product sponsor. This article explains regulatory categorizations under the Food, Drug, and Cosmetic Act and their effects regarding the federal regulation of probiotic products.

Associated Clinical Trials

References

Dec 1, 1939·American Journal of Public Health and the Nation's Health·W S Frisbie

❮ Previous
Next ❯

Citations

Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carmen Tamayo
Aug 3, 2011·BMC Medicine·Girish C DeshpandeSanjay K Patole
Apr 7, 2016·International Journal of Pharmaceutics·Géraldine BroeckxFilip Kiekens
Aug 5, 2010·Clinical Journal of Oncology Nursing·Karen L Visich, Theresa Pluth Yeo
Nov 7, 2016·Trends in Pharmacological Sciences·Thomas M Kuntz, Jack A Gilbert
Feb 17, 2017·Journal of the American Veterinary Medical Association·Maria C JuganChen Gilor
Apr 1, 2017·Critical Reviews in Food Science and Nutrition·Philippe E RamosAntónio A Vicente
Sep 22, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mduduzi Paul Mokoena
Feb 6, 2019·Advances in Nutrition·Julio Plaza-DiazAngel Gil
Aug 3, 2019·Alimentary Pharmacology & Therapeutics·Nienke KoopmanAdriaan G Holleboom
Nov 22, 2019·Journal of Neurogastroenterology and Motility·Yen-Po WangChing-Liang Lu
Oct 16, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·William E Bennett
Sep 19, 2019·Probiotics and Antimicrobial Proteins·José Luis Aleixandre-TudóRafael Aleixandre-Benavent
Nov 23, 2019·Nutrients·Chencheng Xie, Dina Halegoua-DeMarzio
Jan 29, 2019·Frontiers in Pharmacology·Paulo José BassoHelioswilton Sales-Campos
Jun 28, 2019·Nature Reviews. Nephrology·Björn MeijersHans-Joachim Anders
Nov 15, 2020·The Veterinary Clinics of North America. Small Animal Practice·Silke Salavati Schmitz
Feb 18, 2021·Microbial Cell Factories·Shiman JiangLanjuan Li
Dec 18, 2020·The Journal of Infectious Diseases·Laurel A LagenaurThomas P Parks
Feb 27, 2018·ACS Applied Materials & Interfaces·Xin TianJun-Jie Yin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Harunobu Amagase
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Freddie Ann Hoffman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Freddie Ann Hoffman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Maija Saxelin
© 2021 Meta ULC. All rights reserved